Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET binding factor 1 pseudogene 2 (SBF1P2) is a processed genomic pseudogene located on human chromosome 1:11877770-11880406[5]. It is homologous to the SET binding factor 1 gene (SBF1), a catalytically inactive phosphatase that is functionally implicated in neuronal autophagy and peripheral neuropathy—specifically Charcot-Marie-Tooth disease—via its parental gene, but SBF1P2 itself lacks coding capacity and is not translated into a functional protein[1][2][3][5]. Pseudogenes such as SBF1P2 are generally nonfunctional DNA elements resulting from duplication or retrotransposition events; some may act as non-coding regulatory RNAs, but there is no evidence to date that SBF1P2 has such activity[4]. It is not considered a therapeutic target in current biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET binding factor 1 pseudogene 2 (SBF1P2).